-New York Times Report
Related Posts
Novartis Announces $250M In R&D Funding For Neglected Tropical Diseases, Malaria
Novartis AG (NYSE:NVS) is pledging $250 million into R&D for new treatments of neglected tropical diseases (NTD) and malaria, with an…
Elon Musk Will Not Face ‘Gag Order’ Over 2018 Tweet, Judge Rules
A federal judge has ruled that Tesla Inc (NASDAQ: TSLA) CEO Elon Musk will not be subjected to a “gag order” that stops him from discussing a lawsuit claiming he defrauded shareholders with his 2018 tweet about taking the electric
HAVN Life is Looking for a Safe Haven to Mental Health Through Psychedelic Medicine
Most companies' success stories come as a result of wanting to accomplish a greater purpose. For HAVN Life Sciences Inc. (CSE: HAVN) (OTC PINK: HAVLF) (FSE: 5NP) CEO Tim Moore, his personal experience took him to explore alternatives beyond traditional pharma.